Sarcoma of Bone Clinical Trials

6 recruiting

Frequently Asked Questions

Common questions about Sarcoma of Bone clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 111 of 11 trials

Recruiting

Comparing Carbon Ion Therapy, Surgery, and Proton Therapy for Management of Pelvic Sarcomas Involving the Bone

ChondrosarcomaBone SarcomaChordoma+2 more
Mayo Clinic72 enrolled3 locationsNCT05033288
Recruiting

GISAR German Interdisciplinary Sarcoma Registry

SarcomaSarcoma,Soft TissueSarcoma of Bone+1 more
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest9,000 enrolled21 locationsNCT04122872
Recruiting
Not Applicable

Liquid Biopsy in Ewing Sarcoma and Osteosarcoma as a Prognostic And Response Diagnostic: LEOPARD

Ewing SarcomaPeripheral Primitive Neuroectodermal TumorHigh Grade Osteosarcoma+4 more
Dana-Farber Cancer Institute340 enrolled15 locationsNCT06068075
Recruiting

Observational Study on Skeletal Ewing's Sarcoma

Ewing Sarcoma of Bone
Italian Sarcoma Group100 enrolled19 locationsNCT04845893
Recruiting
Phase 1Phase 2

Sequential Infusion of CD146-Targeted and HER2-Targeted CAR T Cells in Patients With Advanced Sarcomas

SarcomaSarcoma, SynovialSarcoma,Soft Tissue+6 more
Essen Biotech60 enrolled1 locationNCT07066982
Recruiting

Tissue Expression of Krüppel-Like Factors 4 and 7 in Bone Tumors

Osteosarcoma in ChildrenEwing Sarcoma of Bone or Soft Tissue
Ain Shams University30 enrolled2 locationsNCT06935864
Recruiting

The Sarcoma Biology and Outcome Project

SarcomaSarcoma of Bone and Connective TissueMalignant Mesenchymoma
Prof. Dr. Richard F Schlenk3,000 enrolled1 locationNCT04758325
Recruiting
Phase 2

Phase II Clinical Trial of Chidamide Combined With AK112 for Second-line and Advanced Bone and Soft Tissue Sarcoma

SarcomaSarcoma,Soft TissueSarcoma of Bone
Shanxi Province Cancer Hospital30 enrolled1 locationNCT06637007
Recruiting
Not Applicable

3D Printed Implants for the Defect Reconstruction in Patients With Chest Wall Tumors

SurgeryChest Wall TumorSarcoma of Bone+3 more
Blokhin's Russian Cancer Research Center30 enrolled1 locationNCT05057143
Recruiting
Phase 2Phase 3

Neoadjuvant Combination of Doxorubicin, Cisplatin and Methotrexate in Patients Aged 24-40 Years With Primary Bone Tumors

SarcomaOsteosarcomaSarcoma of Bone+2 more
Blokhin's Russian Cancer Research Center50 enrolled1 locationNCT05057130
Recruiting
Phase 2

PARP Inhibition, Stereotactic Body Radiotherapy and Immunotherapy for Metastatic or Advanced Sarcoma (PRIMA)

SarcomaSarcoma,Soft TissueSarcoma of Bone
Ruijin Hospital86 enrolled1 locationNCT06074692